Low-level laser therapy is a non-invasive treatment for TMJ symptoms that uses light to stimulate cellular activity, and it's ...

New research reveals how sleep apnea may accelerate brain aging and cognitive decline, with experts sharing crucial insights ...

Pitolisant hydrochloride is under clinical development by Bioprojet SCR and currently in Phase II for Autism Spectrum Disorder (ASD).

Scientists have developed several treatments for sleep maintenance insomnia ... and post-traumatic stress disorder (PTSD). Respiratory problems and reduced mobility can also lead to insomnia.

The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.

There has also been a much-needed shift in importance from ‘treatment of insomnia’ to ‘prevention of sleep disorders and maintenance of good sleep health’. The array of consequences of ...

Cannabidiol is under clinical development by Jazz Pharmaceuticals and currently in Phase II for Rett Syndrome.

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the ...

As we explored in the first part of this post, many aspects of what it means to have an eating disorder—psychological, physical, and behavioural—interfere with good sleep. Bad sleep in turn ...

The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...

The Food and Drug Administration approved Eli Lilly's blockbuster weight loss drug Zepbound for treating patients with the ...

“Of importance, if sleep apnea affects the brain health and increases the risk for dementias, then treatment of it can serve ...